Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaccine and antibody therapy for metastatic colorectal cancer
NCT00007826Phase 2Unknown
- Sponsor
- Onyvax
- Start
- Apr 2000
- Modality
- Prophylactic Vaccines, Cell Therapies, Therapeutic Vaccines
- Countries
- 1
01
Overview
Phase 2, open-label trial of 105AD7, ONYCR1 and ONYCR2 in colorectal cancer (CRC) (3 arms), sponsored by Onyvax. Primary endpoints: Safety and Tolerability and Immunological Response. Status: unknown.
02
Drugs
105AD7ONYCR1ONYCR2
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00007826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00007826.